Comment on “Systematic Review and Meta-Analysis of Diagnostic Accuracy of miRNAs in Patients with Pancreatic Cancer”

Pancreatic cancer is one of the most malignant and aggressive cancers, with poor survival rates and diagnosis being based on nonspecific tumour biomarkers. Due to this, the publication, “Systematic Review and Meta-Analysis of Diagnostic Accuracy of miRNAs in Patients with Pancreatic Cancer”, by Sun...

Full description

Saved in:
Bibliographic Details
Published inDisease markers Vol. 2018; no. 2018; pp. 1 - 2
Main Authors Baxi, Siddhartha, Ramesh, N., Sabarimurugan, Shanthi, Pandey, Venkatesh, Madhav, Madurantakam Royam, Kumarasamy, Chellan, Jayaraj, Rama, Gothandam, K. M.
Format Journal Article
LanguageEnglish
Published Cairo, Egypt Hindawi Publishing Corporation 01.01.2018
Hindawi
Hindawi Limited
Subjects
Accuracy
Biomarkers
Biomarkers, Tumor
Diagnostic systems
Diagnostic tests
Humans
Letter to the Editor
Meta-analysis
MicroRNAs
Pancreatic cancer
Pancreatic Neoplasms
Studies
Systematic review
Online AccessGet full text

Cover

More Information
Summary:Pancreatic cancer is one of the most malignant and aggressive cancers, with poor survival rates and diagnosis being based on nonspecific tumour biomarkers. Due to this, the publication, “Systematic Review and Meta-Analysis of Diagnostic Accuracy of miRNAs in Patients with Pancreatic Cancer”, by Sun et al. has excellent potential for highlighting potential miRNAs as high-accuracy diagnostic markers in pancreatic cancer [1]. However, we believe that despite the comprehensive study conducted by Sun et al., there are a few improvements that could be made to heighten the clinical utility of the paper further. As it stands, we believe that the study has some issues that prevent such applications of Sun et al.’s study.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Commentary-3
content type line 23
Academic Editor: Nelson Yee
ISSN:0278-0240
1875-8630
DOI:10.1155/2018/6904569